{"transactions":[{"id":2428808,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":131178,"kind":"person","name":"Thomson Peter G.","position":1,"cik":"0001779120","reported_name":"Thomson Peter G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & Accounting"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-21T16:15:41.000Z","date":"2022-01-19","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 19, 2022 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2022, subject to continued service."}],"balance_after":40000,"derivative":{"exercise_price":12.69,"expiration_date":"2032-01-18","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000899243-22-002881","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779120/000089924322002881/doc4.xml","form_type":"4"}},{"id":2651899,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":131178,"kind":"person","name":"Thomson Peter G.","position":1,"cik":"0001779120","reported_name":"Thomson Peter G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & Accounting"}}],"security":"Common Stock","published_at":"2021-06-29T16:15:58.000Z","date":"2021-06-28","kind":"purchase","acquired":true,"shares":2300,"price":9,"value":20700.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held by the Reporting Person's child."}],"balance_after":2300,"source":{"system":"sec-edgar","filing":"0000899243-21-026555","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779120/000089924321026555/doc4.xml","form_type":"4"}},{"id":2836101,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":131178,"kind":"person","name":"Thomson Peter G.","position":1,"cik":"0001779120","reported_name":"Thomson Peter G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & Accounting"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-24T16:30:24.000Z","date":"2021-02-22","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying the option are scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2019, subject to continued service."}],"balance_after":50471,"derivative":{"exercise_price":7.84,"expiration_date":"2029-01-21","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000899243-21-008015","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1779120/000089924321008015/doc4.xml","form_type":"4"}},{"id":2836100,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":131178,"kind":"person","name":"Thomson Peter G.","position":1,"cik":"0001779120","reported_name":"Thomson Peter G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & Accounting"}}],"security":"Common Stock","published_at":"2021-02-24T16:30:24.000Z","date":"2021-02-22","kind":"sale","acquired":false,"shares":5000,"price":14.7163,"value":73581.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.31 to $15.03, inclusive. The reporting person undertakes to provide to Fulcrum Therapeutics, Inc., any security holder of Fulcrum Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":15212,"source":{"system":"sec-edgar","filing":"0000899243-21-008015","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1779120/000089924321008015/doc4.xml","form_type":"4"}},{"id":2836099,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":131178,"kind":"person","name":"Thomson Peter G.","position":1,"cik":"0001779120","reported_name":"Thomson Peter G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & Accounting"}}],"security":"Common Stock","published_at":"2021-02-24T16:30:24.000Z","date":"2021-02-22","kind":"exercise","acquired":true,"shares":5000,"price":7.84,"value":39200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2020."}],"balance_after":20212,"source":{"system":"sec-edgar","filing":"0000899243-21-008015","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779120/000089924321008015/doc4.xml","form_type":"4"}},{"id":2893584,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":131178,"kind":"person","name":"Thomson Peter G.","position":1,"cik":"0001779120","reported_name":"Thomson Peter G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & Accounting"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-27T16:30:08.000Z","date":"2021-01-25","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 25, 2021 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2021, subject to continued service."}],"balance_after":40000,"derivative":{"exercise_price":13.09,"expiration_date":"2031-01-24","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000899243-21-003472","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779120/000089924321003472/doc4.xml","form_type":"4"}},{"id":2897886,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":131178,"kind":"person","name":"Thomson Peter G.","position":1,"cik":"0001779120","reported_name":"Thomson Peter G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & Accounting"}}],"security":"Common Stock","published_at":"2021-01-25T16:30:09.000Z","date":"2021-01-21","kind":"sale","acquired":false,"shares":6607,"price":14,"value":92498.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 748 shares acquired under the Issuer's employee stock purchase plan on November 13, 2020."}],"balance_after":15212,"source":{"system":"sec-edgar","filing":"0000899243-21-003173","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779120/000089924321003173/doc4.xml","form_type":"4"}},{"id":3152910,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":131178,"kind":"person","name":"Thomson Peter G.","position":1,"cik":"0001779120","reported_name":"Thomson Peter G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & Accounting"}}],"security":"Common Stock","published_at":"2020-05-12T16:15:21.000Z","date":"2020-05-11","kind":"sale","acquired":false,"shares":7500,"price":16,"value":120000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2019."}],"balance_after":21071,"source":{"system":"sec-edgar","filing":"0000899243-20-012820","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779120/000089924320012820/doc4.xml","form_type":"4"}},{"id":3246557,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":131178,"kind":"person","name":"Thomson Peter G.","position":1,"cik":"0001779120","reported_name":"Thomson Peter G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & Accounting"}}],"security":"Common Stock","published_at":"2020-02-26T19:52:44.000Z","date":"2020-02-24","kind":"sale","acquired":false,"shares":250,"price":18.612,"value":4653.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.29 to $19.01, inclusive. The reporting person undertakes to provide to Fulcrum Therapeutics, Inc., any security holder of Fulcrum Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4."}],"balance_after":28571,"source":{"system":"sec-edgar","filing":"0000899243-20-005958","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1779120/000089924320005958/doc4.xml","form_type":"4"}},{"id":3246556,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":131178,"kind":"person","name":"Thomson Peter G.","position":1,"cik":"0001779120","reported_name":"Thomson Peter G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & Accounting"}}],"security":"Common Stock","published_at":"2020-02-26T19:52:44.000Z","date":"2020-02-24","kind":"sale","acquired":false,"shares":2102,"price":17.4326,"value":36643.3252,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.00 to $17.95, inclusive. The reporting person undertakes to provide to Fulcrum Therapeutics, Inc., any security holder of Fulcrum Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4."}],"balance_after":28821,"source":{"system":"sec-edgar","filing":"0000899243-20-005958","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1779120/000089924320005958/doc4.xml","form_type":"4"}},{"id":3246555,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":131178,"kind":"person","name":"Thomson Peter G.","position":1,"cik":"0001779120","reported_name":"Thomson Peter G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & Accounting"}}],"security":"Common Stock","published_at":"2020-02-26T19:52:44.000Z","date":"2020-02-24","kind":"sale","acquired":false,"shares":2648,"price":16.1845,"value":42856.556,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.91, inclusive. The reporting person undertakes to provide to Fulcrum Therapeutics, Inc., any security holder of Fulcrum Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":30923,"source":{"system":"sec-edgar","filing":"0000899243-20-005958","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779120/000089924320005958/doc4.xml","form_type":"4"}},{"id":3301426,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":131178,"kind":"person","name":"Thomson Peter G.","position":1,"cik":"0001779120","reported_name":"Thomson Peter G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & Accounting"}}],"security":"Stock Option (right to buy)","published_at":"2020-01-27T16:28:26.000Z","date":"2020-01-23","kind":"grant","acquired":true,"shares":33100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on January 23, 2020 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2020, subject to continued service."}],"balance_after":33100,"derivative":{"exercise_price":16.87,"expiration_date":"2030-01-22","underlying":"Common Stock","underlying_shares":33100},"source":{"system":"sec-edgar","filing":"0000899243-20-002037","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1779120/000089924320002037/doc4.xml","form_type":"4"}},{"id":3301425,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":131178,"kind":"person","name":"Thomson Peter G.","position":1,"cik":"0001779120","reported_name":"Thomson Peter G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & Accounting"}}],"security":"Common Stock","published_at":"2020-01-27T16:28:26.000Z","date":"2020-01-23","kind":"sale","acquired":false,"shares":262,"price":18.0539,"value":4730.1218,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.98 to $18.26, inclusive. The reporting person undertakes to provide to Fulcrum Therapeutics, Inc., any security holder of Fulcrum Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4."}],"balance_after":33571,"source":{"system":"sec-edgar","filing":"0000899243-20-002037","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1779120/000089924320002037/doc4.xml","form_type":"4"}},{"id":3301424,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":131178,"kind":"person","name":"Thomson Peter G.","position":1,"cik":"0001779120","reported_name":"Thomson Peter G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & Accounting"}}],"security":"Common Stock","published_at":"2020-01-27T16:28:26.000Z","date":"2020-01-23","kind":"sale","acquired":false,"shares":4738,"price":17.1743,"value":81371.8334,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.78 to $17.73, inclusive. The reporting person undertakes to provide to Fulcrum Therapeutics, Inc., any security holder of Fulcrum Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":33833,"source":{"system":"sec-edgar","filing":"0000899243-20-002037","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779120/000089924320002037/doc4.xml","form_type":"4"}},{"id":3459245,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":131178,"kind":"person","name":"Thomson Peter G.","position":1,"cik":"0001779120","reported_name":"Thomson Peter G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2019-07-18T17:26:21.000Z","date":"2019-07-18","kind":"grant","acquired":true,"shares":7078,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on July 18, 2019. The shares underlying the option are scheduled to vest in equal quarterly installments from July 1, 2019 through June 30, 2023."}],"balance_after":7078,"derivative":{"exercise_price":16,"expiration_date":"2029-07-17","underlying":"Common Stock","underlying_shares":7078},"source":{"system":"sec-edgar","filing":"0001104659-19-040965","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779120/000110465919040965/a4.xml","form_type":"4"}}]}